title: Paricalcitol for reduction of albuminuria in diabetes.
authors.forename: Pierre
authors.initials: P
authors.lastname: Delanaye
authors.forename: Christophe
authors.initials: C
authors.lastname: Mariat
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Krzesinski
authors.forename: Etienne
authors.initials: E
authors.lastname: Cavalier
mesh_terms: D000419:Albuminuria / Q000188:drug therapy* / Q000652:urine; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003404:Creatinine / Q000652:urine; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000652:urine; D004872:Ergocalciferols / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016896:Treatment Outcome; D014808:Vitamin D Deficiency / Q000175:diagnosis / Q000188:drug therapy; D030181:Vitamin D Response Element / Q000187:drug effects
chemical_list: D050071:Bone Density Conservation Agents; D004872:Ergocalciferols; C084656:paricalcitol; D003404:Creatinine